March 2026
The global liquid handling technology market size was anticipated to grow USD 7.25 billion in 2025 and is predicted toincrease from USD 7.90 billion in 2026 to USD 17.21 billion by 2035, with a compound annual growth rate (CAGR) of 9.03% during the forecast period from 2026 to 2035.
Several types of laboratories require liquid handling procedures, such as those that analyze petroleum samples and highly flammable compounds or those that find infections in human blood or screen products for food-borne viruses. For the safe handling and movement of liquids from one place to another, scientists rely on both automatic and manual equipment. The global laboratory procedures rely heavily on the liquid handling technology market. Significant increases in productivity can be achieved by manipulating liquid samples and reagents with greater precision, speed, and effectiveness.
Liquid handling equipment in biotechnology has a bright future since a number of changes are predicted to have an impact on the industry. One notable trend is the increasing frequency with which machine learning (ML) and artificial intelligence (AI) are used in liquid handling systems. In order to enable smarter and more effective laboratory operations, AI and ML have the ability to enhance liquid handling practices, anticipate the need for system maintenance, and enhance data analysis.
Automation Promotes the Liquid Handling Technology Market
Automated liquid handling equipment may be found in a wide range of sizes and designs for use in a variety of areas. These devices discharge a predetermined amount of liquid or a sample into a predetermined container using a motorized pipette or syringe that is fastened to a robotic arm. Certain variants have extra lab equipment and can carry out further functions, including heater-cooler plates (link), to satisfy certain needs. With these adjustments, the liquid handling procedure is guaranteed to be as complete, effective, and accurate as possible.
For instance,
Errors Restraint the Liquid Handling Technology Market
Throughout the projected era, the potential for mistakes in automated liquid handling systems might impede the market's expansion. Moreover, during the projection period, a decline in product demand is anticipated due to a shortage of personnel with the necessary skills to operate the system.
The Liquid Handling Technology Market: Sustainability Opportunity
Sustainability is increasingly starting to be prioritized for development in the field of liquid handling systems. Manufacturers are coming up with ways to minimize the environmental impact of their goods. For example, they may reduce plastic waste and increase energy efficiency. This aligns with the broader biotechnology trend towards sustainability, which emphasizes eco-friendly methods more and more.
| Metric | Details |
| Market Size in 2026 | USD 7.90 Billion |
| Projected Market Size in 2035 | USD 17.21 Billion |
| CAGR (2025 - 2034) | 9.03% |
| Leading Region | North America by 42% |
| Historical Data | 2020 - 2023 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2035 |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Products, By Type, By Application, By End-use and By Region |
| Top Key Players | Thermo Fisher Scientific, Inc., Eppendorf SE., Gilson, Inc, Tecan Group Ltd., PerkinElmer, Danaher Corporation, SPT Labtech, Agilent Technologies, Inc and Hamilton Company |
| Segments | Shares % |
| Consumables | 45% |
| Automated Workstations | 25% |
| Small Devices | 30% |
By product, the consumables segment held the largest share of 45% of the liquid handling technology market in 2025. Liquid management is a fundamental aspect of laboratory work that includes everything from straightforward liquid transfers to intricate molecular biology investigations. The choice of consumables, including PCR plates, pipette tips, ELISA plates, cell culture plates, and cryogenic vials, greatly affects the precision, effectiveness, and dependability of laboratory procedures. Choosing the appropriate consumables increases workflow productivity, reduces costs, and ensures precise and consistent outcomes.
For instance,
| Segments | Shares % |
| Semi-automated Liquid Handling | 35.00% |
| Automated Liquid Handling | 40.00% |
| Manual Liquid Handling | 25.00% |
By type, the semi-automated liquid handling segment dominated the liquid handling technology market by 35% share in 2025. Liquid handlers that automate some sample preparation processes enable labs to adopt semi-automation as a means of gradually increasing productivity and improving repeatability. The only labor-intensive part of semi-automated liquid handlers is for the technician to move a hand probe from vessel to vessel; otherwise, the operator must manually adjust quantities on a pipette or keep track of stages in a process.
By type, the automated liquid handling segment is expected to grow at the fastest CAGR in the liquid handling technology market during the forecast period. Complete automation is especially helpful for high-throughput applications where eliminating human movement altogether is necessary. In these circumstances, liquid handling platforms; which have the capacity to treat hundreds of samples at once—become quite useful. Liquid handling platforms guarantee that samples are treated consistently and without variation by automating extremely complicated techniques. In addition to saving time and money for labs and researchers, this increases the accuracy and repeatability of outcomes. Furthermore, fully automated systems are perfect for large-scale screening and analysis projects that need to handle a huge number of samples due to their high throughput capabilities.
For instance,
| Segments | Shares % |
| Drug Discovery & ADME-Tox Research | 34.25% |
| Cancer & Genomic Research | 20.00% |
| Bioprocessing/Biotechnology | 25.00% |
| Others | 20.75% |
By application, the drug discovery & ADME tox research segment held the largest share of 34.25% in the liquid handling technology market in 2025. In drug development, automated liquid handling has become a vital tool, especially for screening campaigns involving millions of molecules. The rapid advancement of assay downsizing and the intense innovation of these devices have a direct impact on the speed at which medication candidates and chemical probes for probing biological systems are discovered.
| Segments | Shares % |
| Academic & Research Institutes | 40.00% |
| Contract Research Organization (CRO) | 30.00% |
| Pharmaceutical & Biotechnology Companies | 30.00% |
By end-use, the academic & research institutes segment dominated the liquid handling technology market by 40% in 2025. Through a variety of perspectives that were never recognized or discussed extensively, research enables an understanding of certain difficulties. A researcher gathers evidence for their findings based on logic and facts, not just their own experiences. Many life science investigations need the manipulation of liquids, but proteomics and genomics research, in particular, depend heavily on it. Dispensing samples of protein or DNA solutions into microwells or onto substrates is necessary for this type of study; additional solutions are frequently needed for the synthesis and analysis stages that follow.
According to region, North America led the liquid handling technology market by 42% in 2025 due to the presence of a thriving biotechnology and pharmaceutical sector, which necessitates sophisticated laboratory automation solutions for drug discovery and development processes. The adoption of these technologies is also fueled by the growing importance of precision medicine and personalized healthcare, as well as large investments in research and development.
Canada comes in 8th place globally with a 2.2% market share in pharmaceutical sales. Name-brand medications account for 25.7% of prescriptions by amount and 80.5% of overall sales in Canada in terms of value. When it comes to prescription drugs, generics account for 74.3% of the market share and 19.5% of revenues. Over the period of 2018 to 2022, Canada's pharmacy imports and exports to other countries increased by 38% and 55%, respectively.
In 2023, North America led the Liquid Handling Technology Market with a notable revenue of $2,510.00 million. This strong performance highlights the region’s advanced technological capabilities and high demand for innovative liquid handling solutions. Driven by its well-established healthcare and pharmaceutical industries, North America continues to be at the forefront of adopting new technologies that improve precision and efficiency in liquid handling processes.
By region, Asia Pacific is expected to grow at the fastest rate during the forecast period. The sectors with the fastest growth have been biopharma and biotechnology, along with Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) in countries like China, India, and Japan. These industries have made significant advancements in their respective disciplines. Significant investments in the life science fields—omics research, advanced healthcare, microbiology, drug development, and clinical diagnostics—by China, Japan, and India are also expected to drive the growth of the liquid handling technology market.
BIRAC financed 60 bio-incubators, and DBT supported 9 biotech parks. The Department of Biotechnology (DBT) received Rs. 2,251.52 crore (US$ 271 million) in the Interim Budget 2024–25. Thirty MSMEs and over 150 NGOs are among the 101 initiatives that the National Biopharma Mission is funding. The National Biotechnology Development Strategy 2020–25 gives the government a framework for enhancing innovation, resource management, and talent development, which together establish a robust ecosystem for information exchange.
From US$ 10 billion in 2015 to US$ 130 billion in 2024, India's bioeconomy sector has expanded. As of 2021, India's bioeconomy will make up 2.6% of the country's GDP. India is on track to become a $300 billion US bioeconomy by 2030. Biopharma still makes up the overwhelming majority of the Indian bioeconomy. With a projected total economic contribution of US$ 39.4 billion, biopharma accounted for 49% of the bioeconomy. It is estimated that the Indian vaccine market will be valued at Rs. 252 billion (US$ 3.04 billion) by the year 2025. The first-ever locally produced quadrivalent Human Papilloma Virus (qHPV) vaccine against cervical cancer in India was approved for sale by DCGI in July 2022. It was backed by DBT and BIRAC.
Europe is estimated to be a significantly growing region during the forecast period. Because of an aging population, government support is needed for the expansion of the healthcare sector, the availability of state-of-the-art drug research facilities, and the growing use of sophisticated liquid handling technologies. Furthermore, the market for liquid handling systems in the UK grew at the quickest rate in the European area, while the market in Germany had the greatest market share.
Germany Market Trends
With £3.5 billion in investment raised in 2024; a startling 94% increase over the previous year; the UK biotech industry saw tremendous progress. Even in the face of difficult economic conditions, the sector has shown resilient, innovative, and globally appealing, as seen by the largest yearly total since the £4.5 billion generated in 2021. The BioIndustry Association's (BIA) annual UK biotech finance report includes the updated numbers.
South America is seeing growth in the liquid handling technology market, spurred by the quick adoption of automated lab systems aimed at boosting efficiency in biotech and clinical diagnostics. Key factors include major investments in pharmaceutical research, improvements in healthcare infrastructure, and the demand for high-throughput screening. The rising investment in local biotechnology, vaccine production, and clinical research is increasing the need for automated, high-precision liquid handling tools. Government initiatives and funding to enhance healthcare systems and expand diagnostic capabilities, especially after the pandemic, are pushing the demand for modern lab equipment. A heightened emphasis on personalized medicine, genomics, and advanced diagnostic testing necessitates high-throughput screening capabilities offered by automated systems.
Brazil Market Trends
Brazil leads the market in Latin America due to the swift adoption of automation in laboratories, increasing pharmaceutical and biotech R&D, and significant investments in healthcare infrastructure. Its large economy, growing need for precision diagnostics, and strategic collaborations with global manufacturers are driving this expansion. There is a strong and increasing demand for precision, efficiency, and minimizing human error in labs, which has led to a rise in the use of robotic liquid handling workstations. The uptick in drug discovery efforts, development of personalized medicine, and clinical research in Brazil is creating a need for high-throughput screening, thus boosting demand for automated systems. International manufacturers are increasingly setting up direct subsidiaries, enhancing localized application support, and strengthening partnerships in Brazil to satisfy the high demand.
| Company Name | Hamilton |
| Headquarters | Nevada, U.S., North America |
| Recent Development | In May 2024, Hamilton is pleased to announce the debut of ZEUS X1, its newest invention. Hamilton is a leading global provider of automated liquid handling workstations, sample management systems, and precision measurement instruments. ZEUS X1 blends cutting-edge air displacement pipetting technology with Hamilton's cutting-edge CO-RE®II technology, all designed for smooth OEM integration. With a variety of active monitoring and correction techniques, our automated pipetting module overcomes the difficulties associated with pipetting and guarantees process security throughout. |
| Company Name | SPT Labtech |
| Headquarters | Cambridgeshire, United Kingdom, Europe |
| Recent Development | In July 2024, with the introduction of mosquito Gen3, SPT Labtech increased the range of liquid handling products for nanoliters. This new model is the most accessible and small in the mosquito line, and it makes next-generation sequencing (NGS) more affordable for labs by increasing laboratory access to cutting-edge downsizing technology. Within a compact benchtop size, Mosquito Gen3 offers accurate multi-channel pipetting from 500 nL to 5 µL with fast plate-to-plate action across three potential deck locations. |
Strengths
• Automated systems (ALH) deliver better and consistent results than manual methods, which is crucial for sensitive tasks such as genomics and NGS.
• Automation enables round-the-clock operations, accelerating intricate biopharmaceutical processes.
• These systems are applicable in various fields including drug discovery, proteomics, and clinical diagnostics.
• Modern platforms can easily connect with larger laboratory robotic systems.
Weaknesses
• A significant financial investment is necessary, which restricts smaller laboratories from adopting these technologies.
• Complex assays still need a lot of manual preparation before they can be automated.
• Complex systems may have failure points that are hard to identify.
• There is a lack of consistent standards among different instruments and laboratories.
Opportunities
• The growing use of automation in laboratories throughout APAC region, is leading to rapid growth.
• Integrating artificial intelligence (AI) and cloud-based software can create smarter, interconnected laboratory workflows.
• Trends towards miniaturization allow for testing smaller sample sizes, which helps lower reagent costs.
• Increasing investments in life sciences in developing areas present opportunities for growth.
Threats
• Budget limitations in smaller research facilities may restrict their adoption rates.
• Strict and changing regulatory guidelines for medical devices and diagnostics can slow down quick deployment.
• There is a need for specialized skills to operate and maintain advanced liquid handling robotic systems.
• There is fierce competition among major players in a saturated market.
By Products
By Type
By Application
By End-use
By Region
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi ShivarkarMarch 2026
March 2026
March 2026
March 2026
sales@towardshealthcare.com
+1 804-441-9344
